www.diseases-diagnosis.com Homepage Diseases Symptoms Diseases Diagnosis Diseases Treatment Diseases Living Care Diseases Prevention Diseases Research
www
Search
Thursday, September 14th, 2017
Table of Contents

1 Introduction
5 PMID
 [F] Diseases Research  / PubMed Research Articles  /
MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.

PubMed

 

Resource

Canadian journal of physiology and pharmacology 2017 Sep 12; ()

Authors

Miao C1; Zhang G2; Xie Z3; Chang J4;

Author Information
  • 1Anhui Science and Technology University, 177515, Fengyang, Anhui, China ; miaocgastu@126.com.
  • 2School of Science and Technology of Tea and Food, Anhui Agricultural University, Hefei, China ; guoxuezhangah@126.com.
  • 3School of Science and Technology of Tea and Food, Anhui Agricultural University, Hefei, China ; xiezwahau@126.com.
  • 4Fourth Affiliated Hospital, Anhui Medical University, Hefei, China ; junchangah@126.com.

Abstract

MicroRNA (miRNA) is a short non-coding RNA that can influence messenger RNA (mRNA) processing at the post-transcriptional level. A large number of miRNAs have been found in virtually all species so far, and these small molecules play an important role in many different physiological processes and various pathologic conditions, such as cell metabolism, cancer, autoimmune disease, and diabetes mellitus. Type 2 diabetes (T2D) arises from a dysregulated response to the elevated glucose level in the circulation. The prevalence of T2D has increased dramatically in all age groups, and T2D in older adults is associated with more T2D complications and higher mortality. T2D pathology is more complex, despite the existing finding describes the pathological mechanism, but the pathophysiology of the disease is still not fully elucidated. In this review, we summarize the current understanding of miRNA-mediated modulation of gene expression in T2D pathogenesis as well as related signaling pathways, and insight into the important role of miRNA in various T2D complications. Furthermore, the potential therapeutic value of miRNA for T2D patients is also detailed discussed.



PMID

28898588

Others

Publication Type: Journal Article


This article is licensed under the the National Library of Medicine License. It uses material from the PubMed National Library of Medicine Data.


Last Modified:   2016-03-27


Search
All informatin on the site is © www.diseases-diagnosis.com 2002-2016. Last revised: March 27, 2016
Are you interested in our site or/and want to use our information? please read how to contact us and our copyrights.
To let us provide you with high quality information, you can help us by making a more or less donation: